JPS5687517A - Medicinal composition for durable effect type injection - Google Patents

Medicinal composition for durable effect type injection

Info

Publication number
JPS5687517A
JPS5687517A JP16647880A JP16647880A JPS5687517A JP S5687517 A JPS5687517 A JP S5687517A JP 16647880 A JP16647880 A JP 16647880A JP 16647880 A JP16647880 A JP 16647880A JP S5687517 A JPS5687517 A JP S5687517A
Authority
JP
Japan
Prior art keywords
effect type
medicinal composition
type injection
durable effect
durable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16647880A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0128005B2 (enrdf_load_stackoverflow
Inventor
Bakusufuei Nandooru
Harumoshi Ne Fugii Magudoruna
Suzentookirarui Zusuzusanna
Tosu Zorutan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of JPS5687517A publication Critical patent/JPS5687517A/ja
Publication of JPH0128005B2 publication Critical patent/JPH0128005B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP16647880A 1979-11-27 1980-11-26 Medicinal composition for durable effect type injection Granted JPS5687517A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79EE2710A HU180740B (en) 1979-11-27 1979-11-27 Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity

Publications (2)

Publication Number Publication Date
JPS5687517A true JPS5687517A (en) 1981-07-16
JPH0128005B2 JPH0128005B2 (enrdf_load_stackoverflow) 1989-05-31

Family

ID=10995877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16647880A Granted JPS5687517A (en) 1979-11-27 1980-11-26 Medicinal composition for durable effect type injection

Country Status (9)

Country Link
JP (1) JPS5687517A (enrdf_load_stackoverflow)
AT (1) AT371339B (enrdf_load_stackoverflow)
BE (1) BE886310A (enrdf_load_stackoverflow)
DD (1) DD154802A5 (enrdf_load_stackoverflow)
DE (1) DE3044753A1 (enrdf_load_stackoverflow)
FR (1) FR2469924A1 (enrdf_load_stackoverflow)
GB (1) GB2066068B (enrdf_load_stackoverflow)
HU (1) HU180740B (enrdf_load_stackoverflow)
IT (1) IT1149268B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210693B (en) * 1991-10-11 1995-06-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions for injections without tissue damages, containing sulfamethoxazol and trimetoprime
CN100376893C (zh) * 2006-08-18 2008-03-26 中国水产科学研究院黄海水产研究所 同时测定鱼肉中磺胺甲唑、乙酰化磺胺甲唑及甲氧苄啶的液相色谱法
CN113952296B (zh) * 2021-11-15 2023-10-13 山东新华制药股份有限公司 一种复方磺胺甲噁唑注射液的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631779A1 (de) * 1976-07-15 1978-01-19 Basf Ag Sulfonamid-trimethoprim-loesungen

Also Published As

Publication number Publication date
IT8026227A0 (it) 1980-11-26
DD154802A5 (de) 1982-04-21
BE886310A (fr) 1981-05-25
DE3044753A1 (de) 1981-06-19
GB2066068B (en) 1983-08-24
FR2469924A1 (fr) 1981-05-29
DE3044753C2 (enrdf_load_stackoverflow) 1990-05-10
IT1149268B (it) 1986-12-03
GB2066068A (en) 1981-07-08
ATA577380A (de) 1982-11-15
HU180740B (en) 1983-04-29
JPH0128005B2 (enrdf_load_stackoverflow) 1989-05-31
FR2469924B1 (enrdf_load_stackoverflow) 1984-06-29
AT371339B (de) 1983-06-27

Similar Documents

Publication Publication Date Title
DE3070466D1 (en) Injection syringe
GB2039738B (en) Inflammation - preventing pharmaceutical composition
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
JPS5672095A (en) Shampoo composition
JPS5598110A (en) Local administration composition
GB2061727B (en) Dentifrice composition
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
JPS5624443A (en) Molding composition
AU3152677A (en) Pharmaceutical composition
GB2048763B (en) Injection mould
JPS5695949A (en) Molding composition
JPS568747A (en) Rapid injection type masterrcylinder
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
SG28084G (en) Moulding composition
AU2649977A (en) Pharmaceutical composition
ZA806383B (en) Long acting pharmaceutical composition
GB2057880B (en) Dentifrice composition
JPS5687517A (en) Medicinal composition for durable effect type injection
JPS55153704A (en) Agricultural drug composition
JPS54154516A (en) Pharmaceutical composition
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
JPS57114507A (en) Antibacterial composition for injection
JPS5527168A (en) Drug composition
JPS56127311A (en) Novel medicine composition